Evaluation of thickness of retinal nerve fiber layer, ganglion cell layer, and choroidal thickness in essential tremor: can eyes be a clue for neurodegeneration?

  • Ali Zeynel Abidin Tak
  • Yıldızhan Şengül
  • Ayşe Sevgi Karadağ
Original Article
  • 75 Downloads

Abstract

The pathology of essential tremor (ET) and underlying mechanisms of the disease are still unclear, but an increasing amount of research has been conducted on the subject. Discussions are ongoing about ET’s definition as a neurodegenerative disease. Optic coherence tomography (OCT) provides a window to the brain where direct visualization of central nervous system (CNS) changes may be possible, and it can help us to develop a new point of view on ET. The goal of this study was to examine OCT parameters in ET. 40 ET patients and 40 healthy controls, i.e., a total of 160 eyes were evaluated. Retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid thinning were analyzed using spectral domain OCT. The mean age was 25.77 ± 8.98 in the ET group and 27.25 ± 8.22 in the control group. We found a decreased global RNFL thickness for both eyes in ET patients. All GCL and IPL thickness parameters were lower in the patients with ET (P < 0.001, P 0.03). Choroid was significantly thicker in ET patients than the controls (P < 0.001). Our study’s results suggest that the usefulness of OCT in detecting neurodegeneration in ET. RNFL, GCL, IPL measurements are highly reproduced findings of neurodegeneration. Increased choroid volume may indicate neuroinflammation. Eyes in ET may shed light on nature of the disease, and may be used as a diagnostic tool.

Keywords

Optic coherence tomography Essential tremor Retinal nerve fiber layer Ganglion cell layer Choroidal thickness 

Notes

Acknowledgements

We thank Psy. Hakan Serdar Sengul and Dr. Neslihan Cevik for their valuable contribution.

Compliance with ethical standards

Funding

There was no funding source in this study.

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

The study was conducted in accordance with the ethical principles stated in the “Declaration of Helsinki” and was approved by the Ethical Committee of the Adıyaman University Hospital.

Informed consent

Informed consent was obtained from the participants after the nature of the procedures had been fully explained.

References

  1. 1.
    Louis ED, Ottman R, Hauser WA (1998) How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 13:5–10. doi: 10.1002/mds.870130105 CrossRefPubMedGoogle Scholar
  2. 2.
    Louis ED (2010) Essential tremor as a neuropsychiatric disorder. J Neurol Sci 289:144–148. doi: 10.1016/j.jns.2009.08.029 CrossRefPubMedGoogle Scholar
  3. 3.
    Louis ED, Ford B, Frucht S, Barnes LF, X-Tang M, Ottman R (2001) Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 49:761–769. doi: 10.1002/ana.1022 CrossRefPubMedGoogle Scholar
  4. 4.
    Benito-León J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA (2003) Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 18:389–394. doi: 10.1002/mds.10376 CrossRefPubMedGoogle Scholar
  5. 5.
    Louis ED (2009) Essential tremors a family of neurodegenerative disorders? Arch Neurol 66:1202–1208. doi: 10.1001/archneurol.2009.217 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Benito-León J, Louis ED (2006) Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2:666–678. doi: 10.1038/ncpneuro0347 CrossRefPubMedGoogle Scholar
  7. 7.
    Chandran V, Pal PK (2012) Essential tremor: beyond the motor features. Parkinsonism Relat Disord 18:407–413. doi: 10.1016/j.parkreldis.2011.12.003 CrossRefPubMedGoogle Scholar
  8. 8.
    Sengul Y, Sengul HS, Sural MK, Bakim B, Forta H (2015) A comparison between rate of nonmotor symptom development in essential tremor and Parkinson’s disease. Acta Neurol Belg 115:289–294. doi: 10.1007/s13760-014-0408-6 CrossRefPubMedGoogle Scholar
  9. 9.
    Sengul Y, Sengul HS, Yucekaya SK, Yucel S, Bakim B, Pazarcı NK, Özdemir G (2015) Cognitive functions, fatigue, depression, anxiety, and sleep disturbances: assessment of nonmotor features in young patients with essential tremor. Acta Neurol Belg 115:281–287. doi: 10.1007/s13760-014-0396-6 CrossRefPubMedGoogle Scholar
  10. 10.
    Louis ED (2013) “Essential tremor” or “the essential tremors”: is this one disease or a family of diseases? Neuroepidemiology 42:81–89. doi: 10.1159/000356351 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Bonuccelli U (2012) Essential tremor is a neurodegenerative disease. J Neural Transm 119:1383–1387. doi: 10.1007/s00702-012-0878-8 CrossRefPubMedGoogle Scholar
  12. 12.
    Deuschl G, Elble R (2009) Essential tremor–neurodegenerative or non-degenerative disease towards a working definition of ET. Mov Disord 24:2033–2041. doi: 10.1002/mds.22755 CrossRefPubMedGoogle Scholar
  13. 13.
    Jones AL, Sheen NJL, North RV, Morgan JE (2001) The Humphreyoptical coherence tomography scanner: quantitative analysis and reproducibility study of the normal human retinal nervefibrelayer. Br J Ophthalmol 85:673–677CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Blumenthal EZ, Williams JM, Weinreb RN, Girkin CA, Berry CC, Zangwill LM (2000) Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology 107:2278–2282CrossRefPubMedGoogle Scholar
  15. 15.
    Paunescu LA, Schuman JS, Price LL et al. (2007) Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci 45(6):1716–1724CrossRefGoogle Scholar
  16. 16.
    Nolan RC, Narayana K, Galetta SL, Balcer LJ (2015) Optical coherence tomography for the neurologist. Semin Neurol 35:564–577. doi: 10.1055/s-0035-1563579 CrossRefPubMedGoogle Scholar
  17. 17.
    Lamirel C, Newman N, Biousse V (2009) The use of optical coherence tomography in neurology. Rev Neurol Dis 6:105–120. doi: 10.1016/j.neurol.2010.03.024 Google Scholar
  18. 18.
    Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor ad hoc scientific committee. Mov Disord 13:2–23. doi: 10.1002/mds.870131303 CrossRefPubMedGoogle Scholar
  19. 19.
    Chandran V, Pal PK (2012) Essential tremor: beyond the motor features. Parkinsonism Relat Disord 18(5):407–413. doi: 10.1016/j.parkreldis.2011.12.003 (Epub 2012 Jan 2) CrossRefPubMedGoogle Scholar
  20. 20.
    Louis ED (2016) Non-motor symptoms in essential tremor: a review of the current data and state of the field. Parkinsonism Relat Disord 22(Suppl 1):S115–S118. doi: 10.1016/j.parkreldis.2015.08.034 (Epub 2015 Aug 29) CrossRefPubMedGoogle Scholar
  21. 21.
    Sengul Y, Sengul HS, Yucekaya SK, Yucel S, Bakim B, Pazarcı NK, Özdemir G (2015) Cognitive functions, fatigue, depression, anxiety, and sleep disturbances: assessment of nonmotor features in young patients with essential tremor. Acta Neurol Belg 115(3):281–287. doi: 10.1007/s13760-014-0396-6 (Epub 2014 Dec 5) CrossRefPubMedGoogle Scholar
  22. 22.
    Wójcik-Pędziwiatr M, Mirek E, Rudzińska-Bar M, Szczudlik A (2017) Eye movements in essential tremor patients with parkinsonian and cerebellar signs. Neurol Neurochir Pol 51(4):299–303. doi: 10.1016/j.pjnns.2017.05.001 (Epub 2017 May 17) PubMedGoogle Scholar
  23. 23.
    Louis ED, Huang CC, Dyke JP, Long Z, Dydak U (2014) Neuroimaging studies of essential tremor: how well do these studies support/refute the neurodegenerative hypothesis? Tremor Other Hyperkinet Mov (N Y) 28(4):235. doi: 10.7916/D8DF6PB8 (eCollection 2014) Google Scholar
  24. 24.
    Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crew FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453–462. doi: 10.1002/glia.20467 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Polazzi E, Contestabile A (2002) Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 13:221–242CrossRefPubMedGoogle Scholar
  26. 26.
    Cubo E, Tedejo RP, Rodriguez Mendez V, López Peña MJ, Trejo Gabriel y Galán JM (2010) Retina thickness in Parkinson’s disease and essential tremor. Mov Disord 25:2461–2462. doi: 10.1002/mds.23215 CrossRefPubMedGoogle Scholar
  27. 27.
    Turkel Y, Ornek N, Dag E, Ornek K, Alpua M, Ogurel T, Olmez Y (2015) Retinal nerve fiber layer thickness in patients with essential tremor. Neurol Asia 20(4):363–366Google Scholar
  28. 28.
    Kaleagasi H, Fidanci H, Adiguzel U, Dogu O (2015) Evaluation of retinal nerve fiber layer in essential tremor and Parkinson’s disease with optical coherence tomography. Mov Disord 30:4190Google Scholar
  29. 29.
    Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40:2520–2527PubMedGoogle Scholar
  30. 30.
    Huang-Link YM, Fredrikson M, Link H (2015) Benign multiple sclerosis is associated with reduced tinning of the retinal nerve fiber and ganglion cell layers in non-optic-neuritis eyes. J Clin Neurol 11:241–247. doi: 10.3988/jcn.2015.11.3.241 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Serbecic N, Aboul-Enein F, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U (2011) High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One 6:5. doi: 10.1371/journal.pone.0019843.e19843 CrossRefGoogle Scholar
  32. 32.
    Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J (2008) Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Multiple Scler 14:609–614. doi: 10.1177/1352458507087326 CrossRefGoogle Scholar
  33. 33.
    Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying G, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67:749–760. doi: 10.1002/ana.22005 PubMedPubMedCentralGoogle Scholar
  34. 34.
    Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797. doi: 10.1016/j.visres.2004.06.009 CrossRefPubMedGoogle Scholar
  35. 35.
    Altintaş Ö, Işeri P, Özkan B, Çağlar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116:137–146. doi: 10.1007/s10633-007-9091-8 CrossRefPubMedGoogle Scholar
  36. 36.
    Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, Bambo MP, Pablo LE, Fernandez FJ (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye 27:507–514. doi: 10.1038/eye.2013.4 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson’s disease. Br J Ophthalmol 98:350–355. doi: 10.1136/bjophthalmol-2013-304152 CrossRefPubMedGoogle Scholar
  38. 38.
    Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737–741. doi: 10.1001/archophthalmol.2009.106 CrossRefPubMedGoogle Scholar
  39. 39.
    Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges TR III, Kaufmann H (2015) Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord 30:1944–1953. doi: 10.1002/mds.26360 CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, Aktas O, Dietlein T, Lappas A, Foerster A, Hartung HP, Schnitzler A, Methner A (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7:e34891. doi: 10.1371/journal.pone.0034891 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    He X-F, Liu Y-T, Peng C, Zhang F, Zhuang S, Zhang J-S (2012) Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a meta-analysis. Int J Ophthalmol 5:401–405. doi: 10.3980/j.issn.2222-3959.2012.03.30 PubMedPubMedCentralGoogle Scholar
  42. 42.
    Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett 420:97–99. doi: 10.1016/j.neulet.2007.02.090 CrossRefPubMedGoogle Scholar
  43. 43.
    Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F, Sadun AA, Parisi V (2015) Optical coherence tomography in Alzheimer’s disease: a meta-analysis. PLoS One 7:10. doi: 10.1371/journal.pone.0134750.e0134750 Google Scholar
  44. 44.
    Larrosa JM, Garcia-Martin E, Bambo MP, Pinilla J, Polo V, Otin S, Satue M, Herrero R, Pablo LE (2014) Potential new diagnostic tool for Alzheimer’s disease using a linear Discriminant function for Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci 55:3043–3051. doi: 10.1167/iovs.13-13629 CrossRefPubMedGoogle Scholar
  45. 45.
    Sari ES, Koc R, Yazici A, Sahin G, Ermis SS (2015) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol 35:117–121. doi: 10.1097/WNO.0000000000000203 PubMedGoogle Scholar
  46. 46.
    Chorostecki J, Seraji-Bozorgzad N, Shah A, Bao F, Bao G, George E et al (2015) Characterization of retinal architecture in Parkinson’s disease. J Neurol Sci 355:44–52CrossRefPubMedGoogle Scholar
  47. 47.
    Ucak T, Alagoz A, Cakir B, Celik E, Bozkurt E, Alagoz G (2016) Analysis of the retinal nerve fiber and ganglion cell—Inner plexiform layer by optical coherence tomography in Parkinson’s patients. Parkinsonism Relat Disord 31:59–64. doi: 10.1016/j.parkreldis.2016.07.004 CrossRefPubMedGoogle Scholar
  48. 48.
    González-López JJ, Rebolleda G, Leal M, Oblanca N, Munoz-Negrete FJ, Costa-Frossard L, Álvarez-Cermeño José C (2014) Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int 43:1–10. doi: 10.1155/2014/128517 CrossRefGoogle Scholar
  49. 49.
    Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J, Ara JR, Fernandez J, Pablo LE (2014) Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 121:573–579. doi: 10.1016/j.ophtha.2013.09.035 CrossRefPubMedGoogle Scholar
  50. 50.
    Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133:1591–1601. doi: 10.1093/brain/awq080 CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, Venketasubramanian N, Yap P, Seow D, Chen CL, Wong TY (2015) Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 45:45–56. doi: 10.3233/JAD-141659 PubMedGoogle Scholar
  52. 52.
    Garcia-Martin E, Bambo MP, Marques ML, Satue M, Otin S, Larrosa JM, Polo V, Pablo LE (2016) Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer’s disease. Acta Ophthalmol 94:454–459. doi: 10.1111/aos.12977 CrossRefGoogle Scholar
  53. 53.
    Esen E, Sizmaz S, Demir T, Demirkiran M, Unal I, Demircan N (2016) Evaluation of choroidal vascular changes in patients with multiple sclerosis using enhanced depth imaging optical coherence tomography. Ophthalmologica 235:65–71. doi: 10.1159/000441152 CrossRefPubMedGoogle Scholar
  54. 54.
    Eraslan M, Cerman E, YildizBalci S, Celiker H, Sahin O, Temel A, Suer D, Tuncer Elmaci N (2016) The choroid and lamina cribrosa is affected in patients with Parkinson’s disease: enhanced depth imaging optical coherence tomography study. Acta Ophthalmol 94:68–75. doi: 10.1111/aos.12809 CrossRefGoogle Scholar
  55. 55.
    Djamgoz MBA, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509–3529CrossRefPubMedGoogle Scholar

Copyright information

© Belgian Neurological Society 2017

Authors and Affiliations

  • Ali Zeynel Abidin Tak
    • 1
  • Yıldızhan Şengül
    • 2
  • Ayşe Sevgi Karadağ
    • 3
  1. 1.Department of Neurology, School of MedicineAdiyaman University Siteler MahallesiAdiyamanTurkey
  2. 2.Department of NeurologyBezmialem Vakif Universitesi HastanesiIstanbulTurkey
  3. 3.Department of Ophthalmolgy, School of MedicineAdiyaman University Siteler MahallesiAdiyamanTurkey

Personalised recommendations